查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386603

克隆和誘變市場報告：2030 年趨勢、預測和競爭分析

Cloning and Mutagenesis Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

克隆和誘變趨勢和預測

到 2030 年，全球克隆和誘變市場預計將達到 70 億美元，2024 年至 2030 年年複合成長率為 18.0%。該市場的主要驅動力是慢性病和遺傳疾病的日益普及、克隆和誘變技術的日益採用以及對個人化醫療的需求不斷成長。全球克隆和誘變市場的未來前景廣闊，為生物製藥和製藥公司、CRO和CMO以及學術和研究機構市場提供了機會。

克隆和誘變市場洞察

Lucintel 預測，由於克隆套件在基因治療、遺傳分析和生物製藥等廣泛應用中的採用不斷增加，因此在預測期內克隆試劑盒將繼續佔據很大一部分。

由於疾病盛行率不斷增加，生物製藥和製藥公司將繼續成為該市場的最大細分市場。

由於對生物技術的需求不斷增加以及主要企業的存在，北美在預測期內可能仍然是最大的地區。

本報告回答了 11 個關鍵問題：

  • Q.1. 細分市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個細分市場將以更快的速度成長？為什麼？
  • Q.3.您認為哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要挑戰和業務風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球複製與誘變市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球克隆和誘變市場趨勢（2018-2023）和預測（2024-2030）
  • 按產品分類的全球克隆和誘變市場
    • 克隆套件
    • 誘變試劑套件
    • 其他
  • 按技術分類的全球克隆和誘變市場
    • 拓樸PCR克隆
    • 平端克隆
    • 無縫克隆
    • 其他
  • 按最終用途分類的全球克隆和誘變市場
    • 生物製藥和製藥公司
    • 合約研究官（CRO）和首席行銷長（CMO）
    • 學術研究所

第4章 2018-2030年分地區市場趨勢及預測分析

  • 按地區分類的全球克隆和誘變市場
  • 北美克隆和誘變市場
  • 歐洲克隆和誘變市場
  • 亞太克隆與誘變市場
  • 其他區域克隆和誘變市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按產品分類的全球克隆和誘變市場成長機會
    • 全球克隆和誘變市場的技術成長機會
    • 按最終用途分類的全球克隆和誘變市場成長機會
    • 按地區分類的全球克隆和誘變市場成長機會
  • 全球克隆和誘變市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球克隆和誘變市場的產能
    • 全球克隆和誘變市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • Takara Bio
  • Agilent Technologies
  • Thermo Fisher Scientific
  • New England Biolabs
  • Merck
  • Promega
  • Bio-Rad Laboratories
  • Danaher
  • Jena Bioscience
  • Assay Genie
簡介目錄

Cloning and Mutagenesis Trends and Forecast

The future of the global cloning and mutagenesis market looks promising with opportunities in the biopharmaceutical & pharmaceutical company, CROs & CMOs, and academic & research institute markets. The global cloning and mutagenesis market is expected to reach an estimated $7 billion by 2030 with a CAGR of 18.0% from 2024 to 2030. The major drivers for this market are increasing prevalence of chronic diseases and genetic disorders, growing adoption of cloning and mutagenesis technologies, and rising demand for personalized medicine.

A more than 150-page report is developed to help in your business decisions.

Cloning and Mutagenesis by Segment

The study includes a forecast for the global cloning and mutagenesis by product, technology, end use, and region.

Cloning and Mutagenesis Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Cloning Kits
  • Mutagenesis Kits
  • Others

Cloning and Mutagenesis Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Topo PCR Cloning
  • Blunt end Cloning
  • Seamless Cloning
  • Others

Cloning and Mutagenesis Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Biopharmaceutical & Pharmaceutical Companies
  • CROs & CMOs
  • Academic & Research Institutes

Cloning and Mutagenesis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Cloning and Mutagenesis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cloning and mutagenesis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cloning and mutagenesis companies profiled in this report include-

  • Takara Bio
  • Agilent Technologies
  • Thermo Fisher Scientific
  • New England Biolabs
  • Merck
  • Promega
  • Bio-Rad Laboratories
  • Danaher
  • Jena Bioscience
  • Assay Genie

Cloning and Mutagenesis Market Insights

Lucintel forecasts that cloning kits will remain the larger segment over the forecast period due to its increasing adoption in a wide range of applications, such as gene therapy, gene analysis, and biopharmaceuticals.

Within this market, biopharmaceutical & pharmaceutical companies will remain the largest segment due to increasing prevalence of diseases.

North America will remain the largest region over the forecast period due to increasing demand for biotechnology techniques and presence of key players in the region.

Features of the Global Cloning and Mutagenesis Market

Market Size Estimates: Cloning and mutagenesis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cloning and mutagenesis market size by product, technology, end use, and region in terms of value ($B).

Regional Analysis: Cloning and mutagenesis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, technologies, end uses, and regions for the cloning and mutagenesis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cloning and mutagenesis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the cloning and mutagenesis market size?

Answer: The global cloning and mutagenesis market is expected to reach an estimated $7 billion by 2030.

Q.2 What is the growth forecast for cloning and mutagenesis market?

Answer: The global cloning and mutagenesis market is expected to grow with a CAGR of 18.0% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the cloning and mutagenesis market?

Answer: The major drivers for this market are increasing prevalence of chronic diseases and genetic disorders, growing adoption of cloning and mutagenesis technologies, and rising demand for personalized medicine.

Q4. What are the major segments for cloning and mutagenesis market?

Answer: The future of the cloning and mutagenesis market looks promising with opportunities in the biopharmaceutical & pharmaceutical company, CROs & CMOs, and academic & research institute markets.

Q5. Who are the key cloning and mutagenesis market companies?

Answer: Some of the key cloning and mutagenesis companies are as follows:

  • Takara Bio
  • Agilent Technologies
  • Thermo Fisher Scientific
  • New England Biolabs
  • Merck
  • Promega
  • Bio-Rad Laboratories
  • Danaher
  • Jena Bioscience
  • Assay Genie

Q6. Which cloning and mutagenesis market segment will be the largest in future?

Answer: Lucintel forecasts that cloning kits will remain the larger segment over the forecast period due to its increasing adoption in a wide range of applications, such as gene therapy, gene analysis, and biopharmaceuticals.

Q7. In cloning and mutagenesis market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing demand for biotechnology techniques and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the cloning and mutagenesis market by product (cloning kits, mutagenesis kits, and others), technology (topo PCR cloning, blunt end cloning, seamless cloning, and others), end use (biopharmaceutical & pharmaceutical companies, CROs & CMOs, and academic & research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cloning and Mutagenesis Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Cloning and Mutagenesis Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Cloning and Mutagenesis Market by Product
    • 3.3.1: Cloning Kits
    • 3.3.2: Mutagenesis Kits
    • 3.3.3: Others
  • 3.4: Global Cloning and Mutagenesis Market by Technology
    • 3.4.1: Topo PCR Cloning
    • 3.4.2: Blunt end Cloning
    • 3.4.3: Seamless Cloning
    • 3.4.4: Others
  • 3.5: Global Cloning and Mutagenesis Market by End Use
    • 3.5.1: Biopharmaceutical & Pharmaceutical Companies
    • 3.5.2: CROs & CMOs
    • 3.5.3: Academic & Research Institutes

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Cloning and Mutagenesis Market by Region
  • 4.2: North American Cloning and Mutagenesis Market
    • 4.2.2: North American Cloning and Mutagenesis Market by End Use: Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, and Academic & Research Institutes
  • 4.3: European Cloning and Mutagenesis Market
    • 4.3.1: European Cloning and Mutagenesis Market by Product: Cloning Kits, Mutagenesis Kits, and Others
    • 4.3.2: European Cloning and Mutagenesis Market by End Use: Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, and Academic & Research Institutes
  • 4.4: APAC Cloning and Mutagenesis Market
    • 4.4.1: APAC Cloning and Mutagenesis Market by Product: Cloning Kits, Mutagenesis Kits, and Others
    • 4.4.2: APAC Cloning and Mutagenesis Market by End Use: Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, and Academic & Research Institutes
  • 4.5: ROW Cloning and Mutagenesis Market
    • 4.5.1: ROW Cloning and Mutagenesis Market by Product: Cloning Kits, Mutagenesis Kits, and Others
    • 4.5.2: ROW Cloning and Mutagenesis Market by End Use: Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, and Academic & Research Institutes

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Cloning and Mutagenesis Market by Product
    • 6.1.2: Growth Opportunities for the Global Cloning and Mutagenesis Market by Technology
    • 6.1.3: Growth Opportunities for the Global Cloning and Mutagenesis Market by End Use
    • 6.1.4: Growth Opportunities for the Global Cloning and Mutagenesis Market by Region
  • 6.2: Emerging Trends in the Global Cloning and Mutagenesis Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Cloning and Mutagenesis Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cloning and Mutagenesis Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Takara Bio
  • 7.2: Agilent Technologies
  • 7.3: Thermo Fisher Scientific
  • 7.4: New England Biolabs
  • 7.5: Merck
  • 7.6: Promega
  • 7.7: Bio-Rad Laboratories
  • 7.8: Danaher
  • 7.9: Jena Bioscience
  • 7.10: Assay Genie